XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 29, 2022
Oct. 30, 2021
Operating activities:    
Net income $ 90,208 $ 138,614
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 76,698 62,598
Share-based compensation expense 18,117 19,154
Deferred income tax expense 5,222 8,496
Other non-cash expenses 364 530
Changes in operating assets and liabilities:    
Inventories (246,457) (239,840)
Prepaid income taxes and tax receivable (14,064) (17,663)
Prepaid expenses and other assets (21,787) (7,868)
Accounts payable 79,046 115,589
Income taxes payable (28,096) (1,214)
Accrued salaries and wages (39,399) (14,748)
Operating leases 27,271 14,368
Other accrued expenses 7,895 46,649
Net cash (used in) provided by operating activities (44,982) 124,665
Investing activities:    
Purchases of investment securities and other investments (31,815) (285,429)
Sales, maturities, and redemptions of investment securities 273,951 198,295
Capital expenditures (173,589) (213,215)
Net cash provided by (used in) investing activities 68,547 (300,349)
Financing activities:    
Cash paid for Revolving Credit Facility financing costs (248) 0
Net proceeds from issuance of common stock 464 443
Repurchase and retirement of common stock (40,007) 0
Proceeds from exercise of options to purchase common stock and vesting of restricted and performance-based restricted stock units 111 368
Common shares withheld for taxes (4,629) (7,157)
Net cash used in financing activities (44,309) (6,346)
Net decrease in cash and cash equivalents (20,744) (182,030)
Cash and cash equivalents at beginning of period 64,973 268,783
Cash and cash equivalents at end of period 44,229 86,753
Supplemental disclosures of cash flow information:    
Increase in accrued purchases of property and equipment $ (6,008) $ 12,350